Robbie Majzner
Clinical trials sponsored by Robbie Majzner, explained in plain language.
-
First children to receive new 'Living Drug' for tough cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and find the right dose of a new cell therapy for children and young adults whose solid tumors have returned or stopped responding to standard treatments. The therapy, called B7-H3 CAR T cells, uses a patient's own modified immune…
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New 'Living Drug' trial offers hope for kids with tough brain cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of personalized cell therapy called B7-H3 CAR T cells in children and young adults whose brain tumors have come back or gotten worse. The main goals are to find a safe dose and see if the body can successfully make the treatment. Parti…
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC